{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:16:29Z","timestamp":1792826189633,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.tins.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T11:15:45Z","timestamp":1496315745000},"page":"422-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"title":["Unravelling and Exploiting Astrocyte Dysfunction in Huntington\u2019s Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Baljit S.","family":"Khakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahri","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Cachope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Munoz-Sanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Grantyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2017.05.002_bib0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: a perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0015","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0020","doi-asserted-by":"crossref","first-page":"a020362","DOI":"10.1101\/cshperspect.a020362","article-title":"Astrocyte development and heterogeneity","volume":"7","author":"Bayraktar","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1085\/jgp.201210949","article-title":"Imaging calcium microdomains within entire astrocyte territories and endfeet with GCaMPs expressed using adeno-associated viruses","volume":"141","author":"Shigetomi","year":"2013","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.22-01-00183.2002","article-title":"Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains","volume":"22","author":"Bushong","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0035","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1523\/JNEUROSCI.0820-04.2004","article-title":"Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration","volume":"24","author":"Wilhelmsson","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2017.05.002_bib0045","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2017.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rspb.1967.0047","article-title":"Neuroglial cells: physiological properties and a potassium mediated effect of neuronal activity on the glial membrane potential","volume":"168","author":"Kuffler","year":"1967","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.tins.2017.05.002_bib0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1152\/jn.1966.29.4.768","article-title":"Physiological properties of glial cells in the central nervous system of amphibia","volume":"29","author":"Kuffler","year":"1966","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tcb.2016.01.003","article-title":"Probing the complexities of astrocyte calcium signaling","volume":"26","author":"Shigetomi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.neuron.2014.02.007","article-title":"Gliotransmitters travel in time and space","volume":"81","author":"Araque","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrn3725","article-title":"Astrocyte Ca2\u207a signalling: an unexpected complexity","volume":"15","author":"Volterra","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-cellbio-100913-013053","article-title":"Astrocyte regulation of synaptic behavior","volume":"30","author":"Allen","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0080","doi-asserted-by":"crossref","first-page":"a020370","DOI":"10.1101\/cshperspect.a020370","article-title":"Astrocytes control synapse formation, function, and elimination","volume":"7","author":"Chung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-016-1553-1","article-title":"The role of glial-specific Kir4.1 in normal and pathological states of the CNS","volume":"132","author":"Nwaobi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2017.05.002_bib0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","article-title":"Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior","volume":"72","author":"Halassa","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","article-title":"Reactive gliosis and the multicellular response to CNS damage and disease","volume":"81","author":"Burda","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2017.05.002_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.tins.2017.05.002_bib0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2017.05.002_bib0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2017.05.002_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnagi.2013.00012","article-title":"Refining the diagnosis of Huntington disease: the PREDICT-HD study","volume":"5","author":"Biglan","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","author":"T.H.s.D.C.R. Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tins.2017.05.002_bib0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1172\/JCI45646","article-title":"Brain networks in Huntington disease","volume":"121","author":"Eidelberg","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2017.05.002_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2017.05.002_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of Huntington\u2019s disease","volume":"22","author":"Waldvogel","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0145","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.tins.2017.05.002_bib0155","first-page":"1","article-title":"The Neuropathology of Huntington\u2019s disease: classical findings, recent developments and correlation to functional neuroanatomy","volume":"217","author":"Rub","year":"2015","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2017.05.002_bib0165","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2017.05.002_bib0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s disease\u2013an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2017.05.002_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington Study Group","volume":"11","author":"Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2017.05.002_bib0190","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2017.05.002_bib0195","doi-asserted-by":"crossref","first-page":"11251","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2017.05.002_bib0200","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","article-title":"Mutant Huntingtin impairs BDNF release from astrocytes by disrupting conversion of Rab3a-GTP into Rab3a-GDP","volume":"36","author":"Hong","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0205","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2017.05.002_bib0210","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","article-title":"The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases","volume":"35","author":"Ben Haim","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0215","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s11064-004-6881-1","article-title":"Expression specificity of GFAP transgenes","volume":"29","author":"Su","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tins.2017.05.002_bib0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fncel.2015.00144","article-title":"Molecular approaches for manipulating astrocytic signaling in vivo","volume":"9","author":"Xie","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","article-title":"Glutamate toxicity in the striatum of the R6\/2 Huntington\u2019s disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters","volume":"34","author":"Estrada-Sanchez","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0230","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0235","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington\u2019s disease","volume":"100","author":"Miller","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1423-0127-17-62","article-title":"Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6\/2 model of Huntington\u2019s disease","volume":"17","author":"Sari","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tins.2017.05.002_bib0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncir.2013.00188","article-title":"Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3","volume":"7","author":"Wojtowicz","year":"2013","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.tins.2017.05.002_bib0250","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnsys.2011.00026","article-title":"Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington\u2019s disease","volume":"5","author":"Miller","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2017.05.002_bib0270","doi-asserted-by":"crossref","first-page":"e00033","DOI":"10.1042\/AN20090058","article-title":"Genetic mouse models of Huntington\u2019s disease: focus on electrophysiological mechanisms","volume":"2","author":"Cepeda","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.tins.2017.05.002_bib0275","doi-asserted-by":"crossref","first-page":"e1001717","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration","volume":"11","author":"Mielcarek","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0280","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1152\/jn.00791.2004","article-title":"Striatal potassium channel dysfunction in Huntington\u2019s disease transgenic mice","volume":"93","author":"Ariano","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0285","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0290","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0295","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2017.05.002_bib0300","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington\u2019s disease","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0305","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0310","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0315","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2017.05.002_bib0320","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington\u2019s disease","volume":"33C","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0330","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1097\/WNR.0b013e3282f262ca","article-title":"Reduced activity of cortico-striatal fibres in the R6\/2 mouse model of Huntington\u2019s disease","volume":"18","author":"Traficante","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2017.05.002_bib0335","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1113\/jphysiol.2012.241018","article-title":"Tonic mGluR5\/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin","volume":"591","author":"Dvorzhak","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0340","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1523\/JNEUROSCI.20-15-05733.2000","article-title":"Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina","volume":"20","author":"Kofuji","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0345","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1523\/JNEUROSCI.21-15-05429.2001","article-title":"Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination","volume":"21","author":"Neusch","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0350","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1523\/JNEUROSCI.3790-08.2009","article-title":"Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit","volume":"29","author":"Seifert","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0355","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1523\/JNEUROSCI.0723-07.2007","article-title":"Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation","volume":"27","author":"Djukic","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0360","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1523\/JNEUROSCI.2078-10.2010","article-title":"Implication of Kir4.1 channel in excess potassium clearance: an in vivo study on anesthetized glial-conditional Kir4.1 knock-out mice","volume":"30","author":"Chever","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0365","doi-asserted-by":"crossref","first-page":"e1195043","DOI":"10.1080\/21675511.2016.1195043","article-title":"EAST syndrome: clinical, pathophysiological, and genetic aspects of mutations in KCNJ10","volume":"4","author":"Abdelhadi","year":"2016","journal-title":"Rare Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0370","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/jvim.12355","article-title":"A homozygous KCNJ10 mutation in Jack Russell Terriers and related breeds with spinocerebellar ataxia with myokymia, seizures, or both","volume":"28","author":"Gilliam","year":"2014","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tins.2017.05.002_bib0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mcn.2016.10.007","article-title":"Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington\u2019s disease mice","volume":"77","author":"Vagner","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ceca.2009.11.010","article-title":"Glial calcium and diseases of the nervous system","volume":"47","author":"Nedergaard","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.tins.2017.05.002_bib0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1196\/annals.1379.004","article-title":"Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer\u2019s disease","volume":"1097","author":"Takano","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tins.2017.05.002_bib0390","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1169096","article-title":"Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice","volume":"323","author":"Kuchibhotla","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tins.2017.05.002_bib0395","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1038\/ncomms6422","article-title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer\u2019s disease mouse model","volume":"5","author":"Delekate","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2017.05.002_bib0400","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI89354","article-title":"Astrocytic calcium release mediates peri-infarct depolarizations in a rodent stroke model","volume":"127","author":"Rakers","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2017.05.002_bib0405","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington\u2019s disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0410","doi-asserted-by":"crossref","first-page":"13845","DOI":"10.1038\/ncomms13845","article-title":"Astrocytes gate Hebbian synaptic plasticity in the striatum","volume":"7","author":"Valtcheva","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2017.05.002_bib0415","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nbd.2013.06.002","article-title":"Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington\u2019s disease mouse model","volume":"58","author":"Lee","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0420","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.tins.2017.05.002_bib0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00424-013-1397-7","article-title":"SLC1 glutamate transporters","volume":"466","author":"Grewer","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tins.2017.05.002_bib0430","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2017.05.002_bib0435","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington\u2019s disease","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.tins.2017.05.002_bib0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2017.05.002_bib0445","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0450","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2015.10.039","article-title":"Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice","volume":"311","author":"Rothe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2017.05.002_bib0455","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrn2274","article-title":"Glutamate transporters: confining runaway excitation by shaping synaptic transmission","volume":"8","author":"Tzingounis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0460","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nmeth.2333","article-title":"An optimized fluorescent probe for visualizing glutamate neurotransmission","volume":"10","author":"Marvin","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tins.2017.05.002_bib0465","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1523\/JNEUROSCI.0316-16.2016","article-title":"Functional indicators of glutamate transport in single striatal astrocytes and the influence of Kir4.1 in normal and Huntington mice","volume":"16","author":"Dvorzhak","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0470","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.neuroscience.2008.11.018","article-title":"Role of glutamate transporters in corticostriatal synaptic transmission","volume":"158","author":"Beurrier","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2017.05.002_bib0475","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7007-10-26","article-title":"Astrocytes convert network excitation to tonic inhibition of neurons","volume":"10","author":"Heja","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2014.10.008","article-title":"Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities","volume":"20","author":"Jensen","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tins.2017.05.002_bib0490","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","article-title":"Mechanisms of glutamate transport","volume":"93","author":"Vandenberg","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tins.2017.05.002_bib0495","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1113\/JP270362","article-title":"Astrocyte VAMP3 vesicles undergo Ca2+ -independent cycling and modulate glutamate transporter trafficking","volume":"593","author":"Li","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2017.05.002_bib0500","doi-asserted-by":"crossref","first-page":"e28380","DOI":"10.1371\/journal.pone.0028380","article-title":"Simulation of postsynaptic glutamate receptors reveals critical features of glutamatergic transmission","volume":"6","author":"Greget","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2017.05.002_bib0505","doi-asserted-by":"crossref","first-page":"e70791","DOI":"10.1371\/journal.pone.0070791","article-title":"Control of cleft glutamate concentration and glutamate spill-out by perisynaptic glia: uptake and diffusion barriers","volume":"8","author":"Kessler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2017.05.002_bib0510","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0515","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/mol.107.037333","article-title":"Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors","volume":"72","author":"Erreger","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tins.2017.05.002_bib0520","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1093\/cercor\/bhv054","article-title":"Dynamics of ionic shifts in cortical spreading depression","volume":"25","author":"Enger","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.tins.2017.05.002_bib0525","doi-asserted-by":"crossref","first-page":"e1004137","DOI":"10.1371\/journal.pcbi.1004137","article-title":"The neuroglial potassium cycle during neurotransmission: role of Kir4.1 channels","volume":"11","author":"Sibille","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0530","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnana.2010.00151","article-title":"Cellular and synaptic localization of EAAT2a in human cerebral cortex","volume":"4","author":"Melone","year":"2011","journal-title":"Front. Neuroanat"},{"key":"10.1016\/j.tins.2017.05.002_bib0535","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0540","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease","volume":"22","author":"Valenza","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2017.05.002_bib0545","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.tins.2017.05.002_bib0550","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tins.2017.05.002_bib0555","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stem.2012.12.015","article-title":"Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice","volume":"12","author":"Han","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2017.05.002_bib0560","doi-asserted-by":"crossref","first-page":"16153","DOI":"10.1523\/JNEUROSCI.1510-14.2014","article-title":"A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia","volume":"34","author":"Windrem","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0565","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tins.2017.05.002_bib0570","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ydbio.2004.08.018","article-title":"CD44 expression identifies astrocyte-restricted precursor cells","volume":"276","author":"Liu","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0575","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuron.2016.11.030","article-title":"New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes in situ and in vivo","volume":"92","author":"Srinivasan","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0580","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2017.03.023","article-title":"Mutant huntingtin disrupts the nuclear pore complex","volume":"94","author":"Grima","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0585","doi-asserted-by":"crossref","first-page":"e21616","DOI":"10.7554\/eLife.21616","article-title":"Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington\u2019s disease","volume":"5","author":"Atherton","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.tins.2017.05.002_bib0590","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.neuron.2013.10.034","article-title":"Evolving concepts of gliogenesis: a look way back and ahead to the next 25 years","volume":"80","author":"Freeman","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2017.05.002_bib0595","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2017.05.002_bib0600","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2017.05.002_bib0605","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2017.05.002_bib0610","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1047-8477(02)00006-0","article-title":"A cell centered database for electron tomographic data","volume":"138","author":"Martone","year":"2002","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.tins.2017.05.002_bib0615","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijdevneu.2003.12.008","article-title":"Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development","volume":"22","author":"Bushong","year":"2004","journal-title":"Int. J. Dev. Neurosci."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223617300905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223617300905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T14:51:48Z","timestamp":1575384708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223617300905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":123,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0166223617300905"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2017.05.002","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling and Exploiting Astrocyte Dysfunction in Huntington\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}